Y-mAbs Therapeutics (NASDAQ:YMAB) Trading Up 3 9% themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
BAMF, Corewell Health partner on advanced cancer treatment trial| Crain s Grand Rapids Business crainsgrandrapids.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from crainsgrandrapids.com Daily Mail and Mail on Sunday newspapers.
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.
Y-mAbs Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Developments businessinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businessinsider.com Daily Mail and Mail on Sunday newspapers.